Maverick Simulation Solutions Limited Unlisted Share Price
As of , the indicative unlisted share price of Maverick Simulation Solutions Limited is ₹2,295 per share. This is an over-the-counter reference price, not a stock-exchange quote.
As of , Maverick Simulation Solutions Limited is not listed on any Indian stock exchange (NSE or BSE) — its shares trade in the unlisted, over-the-counter (pre-IPO) market.
| Price / unit | ₹2,295 |
|---|---|
| Market cap | ₹1,142 Cr |
| Min. investment | ₹11,475 |
| Lot size | 5 |
| P/E ratio | 23.9 |
| P/B ratio | 10.69 |
What is Maverick Simulation Solutions Limited?
Maverick Simulation Solutions Limited is an unlisted Healthcare company whose shares trade in India's over-the-counter (pre-IPO) market and settle in demat form (NSDL/CDSL).
Maverick Simulation Solutions Limited is a Delhi-based medical technology company that designs and manufactures simulation systems used to train doctors, nurses, surgeons, and allied healthcare professionals. Incorporated in 2023 and headquartered in Dwarka, Delhi, the company builds what are often described as practice machines for medicine, conceptually similar to the flight simulators used to train pilots. Its products allow clinicians to rehearse procedures and clinical decision-making in a controlled, risk-free setting before working with real patients. The company's portfolio spans a broad range of simulation hardware and software, including patient simulators, surgical and procedural trainers, autonomous human lung simulators, and anatomy platforms that integrate augmented reality and virtual reality. Beyond standalone devices, Maverick also sets up turnkey simulation laboratories, supplying the integrated infrastructure that medical colleges, nursing institutes, and hospitals need to run structured skills-training programmes. Its customer base centres on these healthcare and education institutions, with direct sales forming the core of its go-to-market approach. Within India, Maverick operates in a relatively specialised niche, as few domestic firms focus on high-end medical simulation, a field historically dominated by imported systems. This positioning, combined with the broader push toward skills-based medical education and competency assessment in India, has drawn attention to the company. It reported meaningful revenue and profitability in its early financial years and received institutional backing, including an investment from Innovations Venture Studio, while signalling continued spending on AI, AR, and VR capabilities for its next generation of simulators. Because its equity is not listed on any stock exchange, Maverick Simulation Solutions shares trade only in the private, unlisted market through licensed intermediaries. Interest in the unlisted segment typically reflects the company's medtech focus, its niche manufacturing capability, its reported growth, and the structural demand for clinical training infrastructure, rather than any assured outcome. All such activity carries the liquidity and disclosure limitations inherent to unlisted securities.
Explore more unlisted shares
Other companies in our curated selection.
Frequently asked questions
No. As of 16 July 2026, Maverick Simulation Solutions Limited is an unlisted company whose shares trade over-the-counter; it would list only if and when it completes an IPO.
The minimum lot is 5 share(s); at the indicative price of about ₹2,295, that is approximately ₹11,475. Indicative reference, not a quote.
As of 16 July 2026, the indicative unlisted share price of Maverick Simulation Solutions Limited is ₹2,295 per share. This is an over-the-counter reference price, not a stock-exchange quote.
The ISIN of Maverick Simulation Solutions Limited is INE1BEQ01014. An ISIN is the unique 12-character code that identifies a company's shares in the depository system; this one is verified against NSDL (the National Numbering Agency). You need it to hold or transfer these unlisted shares in your NSDL or CDSL demat account.
Maverick Simulation Solutions Limited is a Delhi-based medical technology company that designs and manufactures simulation systems for healthcare training. Its products include patient simulators, surgical and procedural trainers, autonomous human lung simulators, and AR/VR-integrated anatomy platforms, and it also sets up turnkey simulation laboratories for hospitals, medical colleges, and nursing institutes.
No. Maverick Simulation Solutions Limited is currently an unlisted public company and its shares do not trade on the NSE or BSE. Unlisted shares are transferred privately through licensed intermediaries, typically involving price confirmation, KYC verification, document submission, and a transfer of shares into the buyer's demat account. This is informational only and not a recommendation to transact.
The indicative price reflects private over-the-counter transactions and can move with share availability, deal size, the company's reported financial performance, and overall demand in the unlisted market. Because there is no exchange order book, quoted prices are indicative reference points rather than live, continuously traded prices, and they can vary between intermediaries.
The company was incorporated in 2023 and is registered in Delhi under CIN U26600DL2023PLC419501, with ISIN INE1BEQ01014 and a face value of ₹10 per share. It operates in the medical simulation and healthcare-training equipment space, reported revenue and profit in its early financial years, and has received institutional backing. These details are provided for information only.
They can. If the company declares a dividend, unlisted shareholders are eligible like any other shareholder. Many unlisted firms reinvest profits, so dividends are not guaranteed.
After listing, unlisted shares convert into regular listed shares in your demat account and can be traded on the exchange, usually once any applicable SEBI lock-in period ends.
Unlisted shares are less liquid than listed shares. You can sell when a buyer is available through an off-market transfer; there is no continuous exchange market, so exits can take longer.
Unlisted shares carry higher risk and lower liquidity than listed shares, with fewer disclosures and no live market price. This is general information, not investment advice — assess suitability before investing.
An unlisted share price is an indicative, over-the-counter reference set by demand and supply in private deals between buyers and sellers. There is no live exchange quote, so prices can vary across dealers and over time.
Yes. Unlisted shares are delivered in dematerialised form, so you need an active demat account (NSDL or CDSL). No special account type is required — a regular demat account works.
Unlisted shares are sold through an off-market transfer to a buyer via a registered intermediary, settling from your demat account with a contract note. Liquidity depends on buyer availability, so exits can take longer than listed shares.
Maverick Simulation Solutions Limited vs similar unlisted Healthcare shares
Indicative over-the-counter prices, as of 16 July 2026. Information only — not a recommendation or ranking.